Eradication of Helicobacter pylori by 7-day triple-therapy regimens combining pantoprazole with clarithromycin, metronidazole, or amoxicillin in patients with peptic ulcer disease:: Results of two double-blind, randomized studies

被引:39
作者
Bochenek, WJ
Peters, S
Fraga, PD
Wang, WJ
Mack, ME
Osato, MS
El-Zimaity, HMT
Davis, KD
Graham, DY
机构
[1] Vet Affairs Med Ctr, Dept Med, Houston, TX 77030 USA
[2] Baylor Coll Med, Houston, TX 77030 USA
[3] Wyeth Res, Philadelphia, PA USA
关键词
pantoprazole; Helicobacter pylori; eradication; antibiotics; 7-day triple therapy;
D O I
10.1111/j.1523-5378.2003.00179.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Aim. To compare the short-term (7-day) safety and efficacy of two triple-therapy regimens using pantoprazole with those of two dual-therapy regimens (one with pantoprazole and one without), for Helicobacter pylori eradication in patients with peptic ulcer disease. Methods. H. pylori infection was identified by rapid urease (CLOtest), and confirmed by histology and culture. Patients were enrolled into one of two randomized, double-blind, multicenter, parallel-group studies. In study A, patients received oral pantoprazole 40 mg, clarithromycin 500 mg, and metronidazole 500 mg (PCM); pantoprazole, clarithromycin and amoxicillin 1000 mg (PCA); or pantoprazole and clarithromycin (PC). In study B, patients received PCM, PCA, PC, or clarithromycin and metronidazole without pantoprazole (CM). Treatments were given twice daily for 7 days. H. pylori status after therapy was assessed by histology and culture at 4 weeks after completing the course of study treatment. Modified intent-to-treat (MITT; each study: n = 424, n = 512) and per-protocol (PP; each study: n = 371, n = 454) populations were analyzed. The MITT population comprised all patients whose positive H. pylori status was confirmed by culture and histology; the PP population comprised patients who also complied with greater than or equal to 85% of study medication doses. Results. A total of 1016 patients were enrolled. Cure rates among patients with clarithromycin-susceptible H. pylori strains were 82 and 86% for PCM, and 72 and 71% for PCA, in studies A and B, respectively. Cure rates among patients with metronidazole-susceptible H. pylori strains were 82 and 87% for PCM, and 71 and 69% for PCA, in studies A and B, respectively. The combined eradication rates observed with the PCM regimen were superior to those of all other regimens tested. Side-effects were infrequent and mild. Conclusions. PCM had the highest overall eradication rate in these two studies examining 7-day treatment regimens. All regimens were safe and well tolerated.
引用
收藏
页码:626 / 642
页数:17
相关论文
共 128 条
  • [1] Pantoprazole suppresses Helicobacter pylori without affecting cure
    Adamek, RJ
    Szymanski, C
    Pfaffenbach, B
    [J]. HELICOBACTER, 1999, 4 (04) : 266 - 271
  • [2] Cure of H-pylori infection using a 7-day triple therapy combining pantoprazole with two antibiotics
    Adamek, RJ
    Pfaffenbach, B
    Szymanski, C
    [J]. HELICOBACTER, 1998, 3 (03) : 206 - 211
  • [3] Adamek RJ, 1998, AM J GASTROENTEROL, V93, P1919, DOI 10.1111/j.1572-0241.1998.459_a.x
  • [4] SHORT-TERM TRIPLE TREATMENT OF HELICOBACTER-PYLORI INFECTION WITH PANTOPRAZOLE, CLARITHROMYCIN AND METRONIDAZOLE
    ADAMEK, RJ
    SZYMANSKI, C
    PFAFFENBACH, B
    OPFERKUCH, W
    RICKEN, D
    WEGENER, M
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1995, 120 (11) : 358 - 360
  • [5] Primary and acquired Helicobacter pylori resistance to clarithromycin, metronidazole, and amoxicillin -: Influence on treatment outcome
    Adamek, RJ
    Suerbaum, S
    Pfaffenbach, B
    Opferkuch, W
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 1998, 93 (03) : 386 - 389
  • [6] Adamek RJ, 1997, AM J GASTROENTEROL, V92, P1949
  • [7] Clarithromycin resistance stability in Helicobacter pylori:: influence of the MIC and type of mutation in the 23S rRNA
    Alarcón, T
    Domingo, D
    Prieto, N
    López-Brea, M
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (04) : 613 - 616
  • [8] Potentiation of the action of metronidazole on Helicobacter pylori by omeprazole and bismuth subcitrate
    Andersen, LP
    Colding, H
    Kristiansen, JE
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2000, 14 (03) : 231 - 234
  • [9] A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients
    Asaka, M
    Sugiyama, T
    Kato, M
    Satoh, K
    Kuwayama, H
    Fukuda, Y
    Fujioka, T
    Takemoto, T
    Kimura, K
    Shimoyama, T
    Shimizu, K
    Kobayashi, S
    [J]. HELICOBACTER, 2001, 6 (03) : 254 - 261
  • [10] Bardhan KD, 1998, ALIMENT PHARM THERAP, V12, P185